GABRA2‐related encephalopathy: Identification of two phenotypes with distinctive electroclinical features
Open Access
Abstract
Pathogenic variants in γ‐aminobutyric acid type A (GABAA) receptor subunit genes are increasingly associated with epilepsy and neurodevelopmental disorders. Pathogenic variants in GABRA2, encoding the α‐2 subunit of GABAA receptors, have been recently reported. This study aims to better delineate the phenotypic spectrum of GABRA2 pathogenic variants. We conducted a retrospective multicenter study, analyzing six new patients with GABRA2 pathogenic variants identified through a French national collaboration. Clinical, electroencephalographic (EEG), and genetic data were reviewed alongside a literature analysis of eight previously reported cases. Two distinct electroclinical phenotypes were identified. The most severe, in four of six patients, featured early infantile developmental and epileptic encephalopathy with an EEG pattern of rapid rhythms suggestive of GABAergic hyperactivity. The milder phenotype, in two of six patients, included later onset, drug‐responsive epilepsy with moderate developmental delay. A literature review confirmed these phenotypes and supported genotype–phenotype correlations, with transmembrane domain variants more frequently associated with severe phenotypes. This study refines the phenotypic spectrum of GABRA2‐related disorders, highlighting two distinct electroclinical phenotypes. The identification of a recognizable EEG pattern of unusual rapid rhythms for age may be a biomarker for early diagnosis of a severe phenotype and suggests a potential underlying gain‐of‐function mechanism, to be confirmed by functional studies.Keywords
This publication has 21 references indexed in Scilit:
- Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variantsEBioMedicine, 2024
- GABRG1 variant as a potential novel cause of epileptic encephalopathy, hypotonia, and global developmental delayAmerican Journal of Medical Genetics Part A, 2022
- Genetic variations in GABA metabolism and epilepsySeizure: European Journal of Epilepsy, 2022
- Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathiesNature Communications, 2022
- Electro-clinical features in epileptic children with chromosome 15q duplication syndromeClinical Neurophysiology, 2021
- Structural analysis of pathogenic missense mutations in GABRA2 and identification of a novel de novo variant in the desensitization gateMolecular Genetics & Genomic Medicine, 2020
- A de novo GABRA2 missense mutation in severe early-onset epileptic encephalopathy with a choreiform movement disorderEuropean Journal of Paediatric Neurology, 2018
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- GABAA receptors: Subtypes provide diversity of function and pharmacologyNeuropharmacology, 2009
- Linkage disequilibrium between the beta frequency of the human EEG and a GABA A receptor gene locusProceedings of the National Academy of Sciences, 2002